4//SEC Filing
Sabba Stephen L 4
Accession 0001104659-24-031806
CIK 0000886163other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 1:27 PM ET
Size
9.8 KB
Accession
0001104659-24-031806
Insider Transaction Report
Form 4
Sabba Stephen L
Director
Transactions
- Exercise/Conversion
Common Stock
2024-03-05+2,893→ 30,819 total - Sale
Common Stock
2024-03-05$74.30/sh−1,893$140,650→ 28,926 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-03-05−2,893→ 419 totalExercise: $67.53Exp: 2024-06-04→ Common Stock (2,893 underlying)
Footnotes (3)
- [F1]These securities, as represented in Column 5, include a grant of 1,142 restricted share units approved by the Board of Directors of the Company at the 2023 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date. They also properly reflect adjustments from the OmniAb Inc. separation from the Issuer. The Shares referenced in Column 5 of Table I as disposed of on the Form 4 filed 5/10/23 for this Reporting Person inadvertently failed correctly to reflect those adjustments. That number should have been 26,784.
- [F2]These securities, as represented in Column 5, were acquired by a grant of 3,312 shares by the Board of Directors of the Company at the 2014 Meeting. That grant vested in full on the first anniversary of the grant date or immediately (x) upon a change in control or a hostile takeover of the Company or (y) the death or permanent disability of the grantee if still serving at that time.
- [F3]This Option was previously reported on the Form 4 filed 6/6/14 as a Grant of 3,312 shares, which vested in full on April 24, 2015, at an exercise price of $67.53 per share, but was adjusted pursuant to the OmniAb Inc. separation from the Issuer.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001442372
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 1:27 PM ET
- Size
- 9.8 KB